In particular, we found that the EGFR modulates in MSCs the expression of miRNAs involved in breast cancer tumorigenesis, as indicated in the OncoMiR database, progression and response to therapeutic regimens, such as miR-574-3p, miR-342-3p and miR-210-3p [23,24,25]. Here, EGFR is linked to breast carcinoma.